1. A Case Control Study on Serum Levels of Potential Biomarkers in Male Breast Cancer Patients.
- Author
-
Ahmed Abdelsalam KE, Asad M, Ahmed MAI, Asdaq SMB, Mohzari Y, Alrashed A, Alghamdi N, Alrami KN, and Alharbi WA
- Subjects
- Biomarkers, Case-Control Studies, Cross-Sectional Studies, Female, Humans, Male, Breast Neoplasms, Breast Neoplasms, Male, Melatonin
- Abstract
The global incidence of breast cancer among men is steadily growing. Despite this, compared to female breast cancer patients, there are very few studies on biomarkers in male breast cancer patients. A cross-sectional case control study was carried out to determine the serum levels of melatonin, ghrelin, dopamine, serotonin, epinephrine, and GABA in male breast cancer. All the recruited patients were obese, old, and had recently been diagnosed with the disease. They had not received any treatment for the cancer until the time of the study. Melatonin and epinephrine serum levels were significantly higher in breast cancer patients compared to their age-matched controls, whereas ghrelin, dopamine, GABA, and serotonin serum levels were lower in patients compared to the control group. The serum levels of most of the studied biomarkers in male breast cancer patients were similar to those observed in female breast cancer patients, except for serum melatonin levels.
- Published
- 2021
- Full Text
- View/download PDF